PDF herunterladen
Bae, Yoon-Soo Cindy et al.: 2023 Procedural Dermatology: Postresidency and Fellowship Compendium, Volume 2 DOI: 10.1055/b-0043-196760

22 Kybella/Deoxycholic Acid/Off-Label Uses

Weitere Informationen

Buch

Herausgeber: Bae, Yoon-Soo Cindy; Ciocon, David H.

Autoren: Bae, Gee Young; Bernstein, Leonard J.; Boker, Andreas; Borash, Jordan; Bosley, Rawn; Brauer, Jeremy A.; Brown, Wilfred; Callaghan, Daniel; Chesnut, Cameron; Christman, Mitalee P.; Criscito, Maressa C.; Ebersole, Trina G.; Emer, Jason; Fabi, Sabrina Guillen; Fazzalari, Amanda; Friedman, Adam; Friedmann, Daniel P.; Geronemus, Roy G.; Goldberg, David J.; Gordon, Samantha; Graber, Emmy M.; Hazan, Ezra; Kent, Rhett A.; Khorasani, Hooman; Lederhandler, Margo H.; Lee, Austin; Li, Monica K.; Lin, Richard L.; Lipp, Michael B.; MacGregor, Jennifer L.; Mann, Margaret; Mehrabi, Joseph N.; Mishra, Vineet; Moak, Teri N.; Morton, Laurel M.; Murgia, Robert D.; Murphy, Emily C.; Paul, Benjamin Curman; Robinson, Deanne Mraz; Rokhsar, Cameron; Saedi, Nazanin; Scott, Jeffrey F.; Shridharani, Sachin M.; Soon, Seaver L.; Steele, Robert Blake; Steuer, Alexa B.; Tamashunas, Nina Lucia; Tan, Andrea; Tisch, Grace M.; Wang, Jordan V.; Weiss, Robert; Yeh, Lindsey; Zumwalt, Michael

Titel: Procedural Dermatology: Postresidency and Fellowship Compendium, Volume 2

Print ISBN: 9783132424074; Online ISBN: 9783132437142; Buch-DOI: 10.1055/b000000254

1. Edition © 2023. Thieme. All rights reserved.
Georg Thieme Verlag KG, Stuttgart,

Fachgebiete: Dermatologie;Allergologie

Thieme Clinical Collections (English Language)



 
Sachin M. Shridharani, Teri N. Moak, Trina G. Ebersole, and Grace M. Tisch

Summary

Fat reduction for facial and body contouring continues to be one of the most sought-after aesthetic procedures. There continues to be a keen interest in permanent reduction of adipocyte deposition by less invasive methods. The introduction of injectable deoxycholic acid has had a profound impact on aesthetic facial and body contouring by offering both clinicians and patients an FDA-approved option to reduce the appearance of unwanted fat. This chapter serves as an overview to assist the clinician interested in incorporating this treatment into their practice and a top line summary of alternatives.

Schlüsselwörter

Kybella - deoxycholic acid - DCA - kythera - fat-reduction - aesthetic facial contouring - liposuction
 
  • 7 FDA. Prescribing information. KYBELLA injection. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206333Orig1s000lbl.pdf. Accessed November 16, 2017
  • 8 KYTHERA Biopharmaceuticals, Inc. KYTHERA Biopharmaceuticals Announces Health Canada Authorization of BELKYRA(TM), a Submental Contouring Injectable Drug(i). Available from: http://www.kythera.com/kythera-biopharmaceuticals-announces-health-canada-authorization-of-belkyra-a-submental-contouring-injectable-drug/. Accessed
  • 9 FDA. FDA Approves Treatment for Fat below the Chin. Available from: http://wayback.archive-it.org/7993/20171115021407/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm444978.htm
  • 10 Cardis MA, DeKlotz CMC. Intralesional deoxycholic acid treatment for fibrofatty residua of involuted infantile hemangiomas: a novel therapeutic approach.. JAMA Dermatol 2018; 154 (6) 735-737 PubMed
    CrossrefPubMedSuche in Google Scholar
  • 12 Fredriksen JH, Rosenqvist E, Wedege E et al. Production, characterization and control of MenB-vaccine “Folkehelsa”: an outer membrane vesicle vaccine against group B meningococcal disease.. NIPH Ann 1991; 14 (2) 67-79, discussion 79–80 PubMed
    PubMedSuche in Google Scholar
  • 13 Yang J, Li ZH, Zhou JJ et al. Preparation and antitumor effects of nanovaccines with MAGE-3 peptides in transplanted gastric cancer in mice.. Chin J Cancer 2010; 29 (4) 359-364 PubMed
    CrossrefPubMedSuche in Google Scholar
  • 14 Yuba E, Sakaguchi N, Kanda Y, Miyazaki M, Koiwai K. pH-responsive micelle-based cytoplasmic delivery system for induction of cellular immunity.. Vaccines (Basel) 2017; 5 (4) E41 PubMed
    CrossrefPubMedSuche in Google Scholar
  • 15 American Society for Aesthetic Plastic Surgery (ASAPS). Aesthetic Plastic Surgery National Data Bank Statistics. Available from: https://www.surgery.org/sites/default/files/Aesthetic-Society_Stats2019Book_FINAL.pdf Accessed June 25, 2020
  • 2 Center for Drug Evaluation and Research. Kybella Medical Review. Application number: 206333Orig1s000. Available from https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/206333Orig1s000MedR.pdf. Accessed June 25, 2020
  • 17 Shridharani SM, Behr KL. ATX-101 (deoxycholic acid injection) treatment in men: insights from our clinical experience.. Dermatol Surg 2017; 43 (Suppl. Suppl 2) S225-S230 PubMed
    PubMedSuche in Google Scholar
  • 18 Ascher B, Hoffmann K, Walker P, Lippert S, Wollina U, Havlickova B. Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study.. J Eur Acad Dermatol Venereol 2014; 28 (12) 1707-1715 PubMed
    PubMedSuche in Google Scholar
  • 20 Jones DH, Carruthers J, Joseph JH et al. REFINE-1, a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial with ATX-101, an injectable drug for submental fat reduction.. Dermatol Surg 2016; 42 (1) 38-49 PubMed
    PubMedSuche in Google Scholar
  • 21 Rzany B, Griffiths T, Walker P, Lippert S, McDiarmid J, Havlickova B. Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study.. Br J Dermatol 2014; 170 (2) 445-453 PubMed
    PubMedSuche in Google Scholar
  • 22 Humphrey S, Dayan SH, Shridharani SM, et al. Personal and Social Impacts of Submental Fat in the US Population. Presented at Fall Clinical Dermatology Conference on Las Vegas, NV, October 20–23, 2016
  • 23 Humphrey S, Dayan SH, Shridharani SM, et al. Social Perceptions before and after Treatment with ATX-101 (Deoxycholic Acid Injection) for Reduction of Submental Fat. Presented at the American Academy of Dermatology Annual Meeting on Orlando, FL, March 3–7, 2017
  • 13 Shridharani SM. Early experience in 100 consecutive patients with injection adipocytolysis for neck contouring with ATX-101 (deoxycholic acid).. Dermatol Surg 2017; 43 (7) 950-958 PubMed
    PubMedSuche in Google Scholar
  • 14 Beer K, Donofrio L, Gross TM, Beddingfield FC III. Clinically Meaningful Reduction in Submental Fat during and after Treatment with ATX-101 in the US/CAN Phase 3 Trials, REFINE-1 and REFINE-2. Presented at American Academy of Dermatology Annual Meeting on San Francisco, CA, March 20–24, 2015
  • 29 Shridharani SM, Chandawarkar AA. Novel expanded safe zone for reduction of submental fullness with ATX-101 injection.. Plast Reconstr Surg 2019; 144 (6) 995e-1001e PubMed
    PubMedSuche in Google Scholar
  • 32 Verma KD, Somenek MT. Deoxycholic acid injection as an effective treatment for reduction of posterior upper torso brassiere strap adiposity.. Plast Reconstr Surg 2018; 141 (1) 200e-202e PubMed
    CrossrefPubMedSuche in Google Scholar
  • 37 Dover JS, Shridharani SM, Bloom JD, Somogyi C, Gallagher CJ. Reduction of submental fat continues beyond 28 days after ATX-101 treatment: results from a post hoc analysis.. Dermatol Surg 2018; 44 (11) 1477-1479 PubMed
    CrossrefPubMedSuche in Google Scholar
  • 40 Jones DH, Carruthers J, Joseph JH et al. REFINE-1, a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial with ATX-101, an injectable drug for submental fat reduction.. Dermatol Surg 2016; 42 (1) 38-49 PubMed
    CrossrefPubMedSuche in Google Scholar
  • 41 Yang H-M, Kim HJ, Park HW et al. Revisiting the topographic anatomy of the marginal mandibular branch of facial nerve relating to the surgical approach.. Aesthet Surg J 2016; 36 (9) 977-982 PubMed
    CrossrefPubMedSuche in Google Scholar
  • 42 Kythera Biopharmaceuticals, Inc. KYBELLA (deoxycholic acid) injection [prescribing information]. Available from: https://www.allergan.com/assets/pdf/kybella_pi. Accessed July 8, 2020
  • 43 Sung CT, Lee A, Choi F, Juhasz M, Mesinkovska NA. Non-submental applications of injectable deoxycholic acid: a systematic review.. J Drugs Dermatol 2019; 18 (7) 675-680 PubMed
    PubMedSuche in Google Scholar
  • 46 Rzany B, Griffiths T, Walker P, Lippert S, McDiarmid J, Havlickova B. Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study.. Br J Dermatol 2014; 170 (2) 445-453 PubMed
    CrossrefPubMedSuche in Google Scholar
  • 47 Ascher B, Hoffmann K, Walker P, Lippert S, Wollina U, Havlickova B. Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study.. J Eur Acad Dermatol Venereol 2014; 28 (12) 1707-1715 PubMed
    CrossrefPubMedSuche in Google Scholar
  • 48 McDiarmid J, Ruiz JB, Lee D, Lippert S, Hartisch C, Havlickova B. Results from a pooled analysis of two European, randomized, placebo-controlled, phase 3 studies of ATX-101 for the pharmacologic reduction of excess submental fat.. Aesthetic Plast Surg 2014; 38 (5) 849-860 PubMed
    CrossrefPubMedSuche in Google Scholar
  • 49 Dayan S, Jones DH, Carruthers J et al. A pooled analysis of the safety and efficacy results of the multicenter, double-blind, randomized, placebo-controlled phase 3 REFINE-1 and REFINE-2 trials of ATX-101, a submental contouring injectable drug for the reduction of submental fat.. Plast Reconstr Surg 2014; 134: 123
    CrossrefSuche in Google Scholar
  • 52 Shridharani SM. Early experience in 100 consecutive patients with injection adipocytolysis for neck contouring with ATX-101 (deoxycholic acid).. Dermatol Surg 2017; 43 (7) 950-958 PubMed
    CrossrefPubMedSuche in Google Scholar